Xiangfeng Shen

657 total citations
18 papers, 522 citations indexed

About

Xiangfeng Shen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiangfeng Shen has authored 18 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiangfeng Shen's work include Neuroendocrine regulation and behavior (2 papers), Tryptophan and brain disorders (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Xiangfeng Shen is often cited by papers focused on Neuroendocrine regulation and behavior (2 papers), Tryptophan and brain disorders (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Xiangfeng Shen collaborates with scholars based in China, United States and India. Xiangfeng Shen's co-authors include Lihong Zhang, Yulin Li, Zhi‐Xiang Xu, Ji‐Cheng Li, Yishu Wang, Qing Huang, Shiyu Du, Xiaobing Zhou, Jaehyeong Lee and Young‐Hwan Han and has published in prestigious journals such as Oncogene, Frontiers in Immunology and Journal of Affective Disorders.

In The Last Decade

Xiangfeng Shen

18 papers receiving 518 citations

Peers

Xiangfeng Shen
Jie Ruan China
Shengnan Xia China
Lingyu Kong China
Xuli Yang China
Jeong Ho Han South Korea
Masaki Ohmori Japan
Hyun‐Kyu An South Korea
Sundaravadivel Balasubramanian United States
Jie Ruan China
Xiangfeng Shen
Citations per year, relative to Xiangfeng Shen Xiangfeng Shen (= 1×) peers Jie Ruan

Countries citing papers authored by Xiangfeng Shen

Since Specialization
Citations

This map shows the geographic impact of Xiangfeng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangfeng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangfeng Shen more than expected).

Fields of papers citing papers by Xiangfeng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangfeng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangfeng Shen. The network helps show where Xiangfeng Shen may publish in the future.

Co-authorship network of co-authors of Xiangfeng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangfeng Shen. A scholar is included among the top collaborators of Xiangfeng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangfeng Shen. Xiangfeng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Li, Rongqun, et al.. (2023). The causality between gut microbiota and ankylosing spondylitis: Insights from a bidirectional two‐sample Mendelian randomization analysis. International Journal of Rheumatic Diseases. 26(12). 2470–2477. 6 indexed citations
2.
3.
Liu, Xiaofeng, et al.. (2021). The convergence of aversion and reward signals in individual neurons of the mice lateral habenula. Experimental Neurology. 339. 113637–113637. 21 indexed citations
4.
Shen, Xiangfeng, Yongran Cheng, Mengyun Zhou, et al.. (2020). Effect of COVID-19 outbreak on the treatment time of patients with acute ST-segment elevation myocardial infarction. The American Journal of Emergency Medicine. 44. 192–197. 9 indexed citations
5.
Shen, Xiangfeng, Yuan Zhao, Guolong Liu, et al.. (2020). Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer. Life Sciences. 256. 117923–117923. 28 indexed citations
6.
Fan, Jingjing, Xiangfeng Shen, Yishu Wang, et al.. (2020). Biomarkers for immune checkpoint therapy targeting programmed death 1 and programmed death ligand 1. Biomedicine & Pharmacotherapy. 130. 110621–110621. 7 indexed citations
7.
Shen, Xiangfeng, et al.. (2019). Role of DNA hypomethylation in lateral habenular nucleus in the development of depressive-like behavior in rats. Journal of Affective Disorders. 252. 373–381. 19 indexed citations
8.
Shen, Xiangfeng, Lihong Zhang, Ji‐Cheng Li, et al.. (2019). Recent Findings in the Regulation of Programmed Death Ligand 1 Expression. Frontiers in Immunology. 10. 1337–1337. 95 indexed citations
9.
Hang, Wei, Gang Liu, Qinghua Zeng, et al.. (2018). Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1. Oncogene. 37(25). 3384–3398. 47 indexed citations
10.
Jiang, Kai, Yurong Jiao, Yue Liu, et al.. (2018). HNF6 promotes tumor growth in colorectal cancer and enhances liver metastasis in mouse model. Journal of Cellular Physiology. 234(4). 3675–3684. 10 indexed citations
11.
Hu, Yeting, Qian Xiao, Haiyan Chen, et al.. (2017). BEX2 promotes tumor proliferation in colorectal cancer. International Journal of Biological Sciences. 13(3). 286–294. 19 indexed citations
12.
Yang, Minlan, Yanru Li, Xiangfeng Shen, et al.. (2017). CLDN6 promotes chemoresistance through GSTP1 in human breast cancer. Journal of Experimental & Clinical Cancer Research. 36(1). 157–157. 60 indexed citations
13.
Hang, Wei, Gang Liu, Yishu Wang, et al.. (2017). PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation. Oncotarget. 9(2). 1885–1897. 17 indexed citations
14.
Li, Jicheng, Yang Li, Beilin Zhang, Xiangfeng Shen, & Hua Zhao. (2016). Why depression and pain often coexist and mutually reinforce: Role of the lateral habenula. Experimental Neurology. 284(Pt A). 106–113. 44 indexed citations
15.
Chen, Haiyan, Zhujing Shen, Yeting Hu, et al.. (2015). Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis. Journal of Cancer Research and Clinical Oncology. 141(12). 2147–2158. 11 indexed citations
16.
Xu, Ting, et al.. (2015). Water-soluble ginseng oligosaccharides protect against scopolamine-induced cognitive impairment by functioning as an antineuroinflammatory agent. Journal of Ginseng Research. 40(3). 211–219. 47 indexed citations
17.
Zhou, Xiaobing, Young‐Hwan Han, Xiangfeng Shen, et al.. (2015). Fast joining SiC ceramics with Ti3SiC2 tape film by electric field-assisted sintering technology. Journal of Nuclear Materials. 466. 322–327. 76 indexed citations
18.
Zheng, Wei‐Jun, Xiangfeng Shen, & Chi Zhou. (2012). [Association between the quality of sleep and the occurrence of diabetes among people with impaired glucose regulation].. PubMed. 33(11). 1141–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jie Ruan Breakdown of academic impact, for papers by Shengnan Xia Breakdown of academic impact, for papers by Lingyu Kong Breakdown of academic impact, for papers by Xuli Yang Breakdown of academic impact, for papers by Jeong Ho Han Breakdown of academic impact, for papers by Masaki Ohmori Breakdown of academic impact, for papers by Hyun‐Kyu An Breakdown of academic impact, for papers by Sundaravadivel Balasubramanian
Rankless by CCL
2026